Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

119,574 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Serum biomarkers in myelin oligodendrocyte glycoprotein antibody-associated disease.
Kim H, Lee EJ, Kim S, Choi LK, Kim K, Kim HW, Kim KK, Lim YM. Kim H, et al. Among authors: kim hw, kim kk, kim s, kim k. Neurol Neuroimmunol Neuroinflamm. 2020 Mar 17;7(3):e708. doi: 10.1212/NXI.0000000000000708. Print 2020 May. Neurol Neuroimmunol Neuroinflamm. 2020. PMID: 32184342 Free PMC article.
Mutant PIK3CA as a negative predictive biomarker for treatment with a highly selective PIM1 inhibitor in human colon cancer.
Park YS, Kim J, Ryu YS, Moon JH, Shin YJ, Kim JH, Hong SW, Jung SA, Lee S, Kim SM, Lee DH, Kim DY, Yun H, You JE, Yoon DI, Kim CH, Koh DI, Jin DH. Park YS, et al. Among authors: kim dy, kim ch, kim sm, kim j, kim jh. Cancer Biol Ther. 2023 Dec 31;24(1):2246208. doi: 10.1080/15384047.2023.2246208. Cancer Biol Ther. 2023. PMID: 37621144 Free PMC article.
CJ14939, a Novel JAK Inhibitor, Increases Oxaliplatin-induced Cell Death Through JAK/STAT Pathway in Colorectal Cancer.
Hong JK, Kim DY, Shin JS, Ryu YS, Moon JH, Koh DI, Lee S, Lee J, Lee WJ, Lee EY, Jung SA, Kim SC, Yu HN, Kim MJ, Hong SW, Park SS, Jung J, Kim SM, Kim EH, Jeong HR, Gong JH, Kim J, Kim TW, Jin DH. Hong JK, et al. Among authors: kim sc, kim eh, kim tw, kim dy, kim sm, kim j, kim mj. Anticancer Res. 2022 Apr;42(4):1813-1819. doi: 10.21873/anticanres.15657. Anticancer Res. 2022. PMID: 35346999
Targeting β-catenin overcomes MEK inhibition resistance in colon cancer with KRAS and PIK3CA mutations.
Moon JH, Hong SW, Kim JE, Shin JS, Kim JS, Jung SA, Ha SH, Lee S, Kim J, Lee DH, Park YS, Kim DM, Park SS, Hong JK, Kim DY, Kim EH, Jung J, Kim MJ, Kim SM, Deming DA, Kim K, Kim TW, Jin DH. Moon JH, et al. Among authors: kim eh, kim tw, kim dy, kim js, kim dm, kim sm, kim je, kim j, kim mj, kim k. Br J Cancer. 2019 Apr;120(9):941-951. doi: 10.1038/s41416-019-0434-5. Epub 2019 Apr 4. Br J Cancer. 2019. PMID: 30944457 Free PMC article.
119,574 results
You have reached the last available page of results. Please see the User Guide for more information.